Promising Dividend Stocks To Follow Now – April 12th
by Amy Steele · The Cerbat GemProShares UltraPro Short QQQ, Chevron, Accenture, Verizon Communications, NIKE, AbbVie, and Direxion Daily TSLA Bull 2X Shares are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their earnings to shareholders as cash payments, typically on a quarterly basis. They appeal to income-seeking investors for steady cash flow and potential total return, though dividends can be reduced or eliminated if the company’s profits or outlook deteriorate. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Read Our Latest Research Report on SQQQ
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
Read Our Latest Research Report on CVX
Accenture (ACN)
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
Read Our Latest Research Report on ACN
Verizon Communications (VZ)
Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business).
Read Our Latest Research Report on VZ
NIKE (NKE)
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.
Read Our Latest Research Report on NKE
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Read Our Latest Research Report on ABBV
Direxion Daily TSLA Bull 2X Shares (TSLL)
Read Our Latest Research Report on TSLL
Read More
- MarketBeat’s Top Five Stocks to Own in April 2026
- With Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?
- 3 Different Fintech Giants: Turnaround, Stability, or Risky Bet?
- Microsoft’s Copilot Problem Isn’t What You Think
- 3 Surprising S&P 500 Outperformers of 2026
- Russell 2000 Tracking for New Highs: What’s Next for ETF Traders?